Device Trial Radar · NCT06053255
Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Sep 13, 2024
Primary completion
May 26, 2027
Study completion Jul 15, 2027
Sponsor
- Lead sponsor
- FUSMobile Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Focused Ultrasound Foundation
- First posted
- Sep 25, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.
Conditions
- Sacroiliitis
Interventions
High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XRDevice
HIFU is delivered via a non-invasive ultrasonic transducer, through a gel pad for acoustic coupling, into the patients body in a precise manner focused on the lateral sacral branch nerves.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number of participants with treatment-related adverse events as assessed by Common Terminology Criteria for Adverse Events (CTCAE) v6.0.Time frame: Procedure through 6 month follow-up visit
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Virginia, Department of Anesthesiology
Charlottesville, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.